Concomitant use may lower systemic exposures and reduce effectiveness of monoclonal antibodies. Closely monitor for reduced effectiveness.
Source: NLP:rozanolixizumab
Monoclonal Antibodies Interactions
1 interaction on record
1 interaction on record
Concomitant use may lower systemic exposures and reduce effectiveness of monoclonal antibodies. Closely monitor for reduced effectiveness.
Source: NLP:rozanolixizumab